This inventor holds 1 USPTO granted patent. Top assignee: Azad Pharmaceutical Ingredients Ag. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Patrick Müller - Innovator in Pharmaceutical Synthesis
Introduction
Patrick Müller is a notable inventor based in Römerswil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of important compounds. His work focuses on developing innovative methods that enhance the efficacy and safety of pharmaceutical products.
Latest Patents
One of Patrick Müller's key patents is titled "Synthetic path to pharmaceutically acceptable Vismodegib." This invention presents a new route of synthesis to obtain pharmaceutically acceptable Vismodegib. The patent also discloses suitable pharmaceutical compositions and the use of the compound for the treatment of basal-cell carcinomas. This advancement is crucial for improving treatment options for patients suffering from this type of cancer.
Career Highlights
Patrick Müller is currently associated with Azad Pharmaceutical Ingredients AG, where he applies his expertise in pharmaceutical synthesis. His innovative approach has led to the development of new methodologies that are beneficial in the pharmaceutical industry. With 1 patent to his name, he continues to push the boundaries of what is possible in drug development.
Collaborations
Throughout his career, Patrick has collaborated with several talented individuals, including Christian Manfred Frech and Pasquale Gabriele Grieco. These collaborations have fostered a creative environment that encourages the exchange of ideas and the advancement of pharmaceutical research.
Conclusion
In summary, Patrick Müller is a dedicated inventor whose work in pharmaceutical synthesis has the potential to significantly impact the treatment of basal-cell carcinomas. His innovative methods and collaborations highlight his commitment to advancing the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile